Register entry

Deciphera Pharmaceuticals, LLC

Data as of · How to read this entry

Registered sites
0
Active NDC listings
4
Live patents
81
Exclusivities
2
Countries
0
Catalogue

Drug listings by form and route

4

4 active NDC listings: 4 human prescription drug. By marketing category: NDA 4.

Dosage formNDCs
capsule3
tablet1
RouteNDCs
oral4
Labeller name on the listingNDCs
deciphera pharmaceuticals, llc4
Exclusivity

Patents and exclusivities

81
PatentProductCoversExpiry
8188113QINLOCKripretinibsubstance, productJul 2030
RE48731QINLOCKripretinibuseJun 2032
9181223ROMVIMZAvimseltinibsubstance, productMar 2034
8461179QINLOCKripretinibsubstance, productMay 2034
12285430ROMVIMZAvimseltinibuseDec 2039
12485120ROMVIMZAvimseltinibuseDec 2039
12582655ROMVIMZAvimseltinibuseDec 2039
11103507ROMVIMZAvimseltinibuseFeb 2040
11679110ROMVIMZAvimseltinibuseFeb 2040
10966966QINLOCKripretinibuseAug 2040
11266635QINLOCKripretinibuseAug 2040
11344536QINLOCKripretinibuseAug 2040
11426390QINLOCKripretinibuseAug 2040
11433056QINLOCKripretinibuseAug 2040
11529336QINLOCKripretinibuseAug 2040
11534432QINLOCKripretinibuseAug 2040
11576904QINLOCKripretinibuseAug 2040
11813251QINLOCKripretinibuseAug 2040
12023325QINLOCKripretinibuseAug 2040
12023326QINLOCKripretinibuseAug 2040
12023327QINLOCKripretinibuseAug 2040
12059410QINLOCKripretinibuseAug 2040
12059411QINLOCKripretinibuseAug 2040
12295944QINLOCKripretinibuseAug 2040
12318373QINLOCKripretinibuseAug 2040
11185535QINLOCKripretinibproductDec 2040
11395818QINLOCKripretinibproductDec 2040
11576903QINLOCKripretinibproductDec 2040
11612591QINLOCKripretinibproductDec 2040
11793795QINLOCKripretinibproductDec 2040
11801237QINLOCKripretinibproductDec 2040
11844788QINLOCKripretinibproductDec 2040
11850240QINLOCKripretinibproductDec 2040
11850241QINLOCKripretinibproductDec 2040
11896585QINLOCKripretinibproductDec 2040
11903933QINLOCKripretinibproductDec 2040
11911370QINLOCKripretinibproductDec 2040
11918564QINLOCKripretinibproductDec 2040
11969415QINLOCKripretinibuseDec 2040
12023328QINLOCKripretinibuseDec 2040
12064422QINLOCKripretinibuseDec 2040
12213967QINLOCKripretinibproductDec 2040
12213968QINLOCKripretinibproductDec 2040
12226406QINLOCKripretinibproductDec 2040
12318374QINLOCKripretinibproductDec 2040
12708617QINLOCKripretinibuseDec 2040
11969414QINLOCKripretinibuseFeb 2041
11779572QINLOCKripretinibuseOct 2042
12447149ROMVIMZAvimseltinibproductDec 2044
12528787ROMVIMZAvimseltinibsubstance, productDec 2044
12551483ROMVIMZAvimseltinibproductDec 2044
12617775ROMVIMZAvimseltinibsubstance, productDec 2044
12643883ROMVIMZAvimseltinibsubstance, productDec 2044
12509443ROMVIMZAvimseltinibproductApr 2045
12686672ROMVIMZAvimseltinibproductApr 2045
ProductExclusivityUntil
QINLOCKRIPRETINIBODE-298 Orphan drugMay 2027
ROMVIMZAVIMSELTINIBNCE New chemical entityFeb 2030
Catalogue

Marketed products

4
BrandGeneric nameForm / routeNDC
QINLOCKRipretinibtablet, oral73207-101NDA
ROMVIMZAVimseltinibcapsule, oral73207-302NDA
ROMVIMZAVimseltinibcapsule, oral73207-303NDA
ROMVIMZAVimseltinibcapsule, oral73207-304NDA
Enquiry

Common questions

Is Deciphera Pharmaceuticals, LLC FDA approved?
Deciphera Pharmaceuticals, LLC holds no registered establishment of its own; 4 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Deciphera Pharmaceuticals, LLC make?
4 products are listed under Deciphera Pharmaceuticals, LLC in the openFDA NDC Directory, most often as capsule; tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.